JABRADIA Trademark

Trademark Overview


On Wednesday, June 20, 2018, a trademark application was filed for JABRADIA with the United States Patent and Trademark Office. The USPTO has given the JABRADIA trademark a serial number of 88008054. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Tuesday, April 2, 2019. This trademark is owned by Pfizer Inc.. The JABRADIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
jabradia

General Information


Serial Number88008054
Word MarkJABRADIA
Filing DateWednesday, June 20, 2018
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateTuesday, April 2, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 23, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateTuesday, April 2, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Tuesday, April 2, 2019ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Tuesday, April 2, 2019ABANDONMENT - AFTER PUBLICATION
Monday, April 1, 2019TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, December 18, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 23, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 23, 2018PUBLISHED FOR OPPOSITION
Wednesday, October 3, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 19, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 19, 2018ASSIGNED TO EXAMINER
Tuesday, June 26, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 23, 2018NEW APPLICATION ENTERED IN TRAM